Page 21

Abril_2107

ARTÍCULO DE INVESTIGACIÓN 429 Subclasificación molecular del cáncer colorrectal - A. M. Wielandt et al Referencias 1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality wordwild: source, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136 E359-86. 2. Bray F, Ferlay J, Laversanne M, Brewster DH, Gombe Mbalawa C, Kohler B, et al. Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration. Int J Cancer 2015; 137 (9): 2060-71. 3. Zárate AJ, Alonso FT, Garmendia ML, López-Köstner F. Increasing crude and adjusted mortality rates for colorectal cancer in a developing South American country. Colorectal Dis 2013; 15 (1): 47-51. 4. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319 (9): 525-32. 5. Vogelstein B, Kinzler KW. The Path to Cancer-Three Strikes and You’re Out. N Engl J Med 2015; 373. 6. Yiu AJ, Yiu CY. Biomarkers in Colorectal Cancer. Anticancer Research 2016; 36: 1093-102. 7. Colussi D, Brandi G, Bazzoli F, Ricciardiello LC. Molecular Pathways Involved in Colorectal Cancer: Implications for disease behavior and prevention. Int J Mol Sci 2013; 14: 16365-85. 8. Kudryavtseva AV, Lipatova AV, Zaretsky AR, Moskalev AA, Fedorova MS, Rasskazova AS, et al. Important molecular genetic markers of colorectal cancer Oncotarget 2016 Jun 2. doi: 10.18632/oncotarget.9796. 9. Watanabe T, Kobunai T, Yamamoto Y, Matsuda K, Ishihara S, Nozawa K, et al. Chromosomal instability (CIN) phenotype, CIN high or CIN low, predicts survival for colorectal cancer. J Clin Oncol 2012; 30 (18): 2256-64. 10. Hveem TS, Merok MA, Pretorius ME, Novelli M, Bævre MS, Sjo OH, et al. Prognostic impact of genomic instability in colorectal cancer BJC 2014; 110: 2159-64. 11. Mouradov D, Domingo E, Gibbs P, Jorissen RN, Li S, Soo PY, et al. Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations Am J Gastroenterol 2013; 108 (11): 1785-93. 12. Issa JP. Colon cancer: it’s CIN or CIMP. Clin Cancer Res 2008; 14 (19): 5939-40. 13. Zhang X, Shimodaira H, Soeda H, Komine K, Takahashi H, Ouchi K, et al. CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer. Int J Clin Oncol 2016; 21 (6): 1091-101. 14. Cha Y, Kim KJ, Han SW, Rhee YY, Bae JM, Wen X, et al. Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer. Br J Cancer 2016; 115 (2): 164-71. 15. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007; 50: 113-30. 16. Sadanandam A, Wang X, de Sousa E Melo F, Gray JW, Vermeulen L, et al. Reconciliation of classification systems defining molecular subtypes of colorectal cáncer: Interrelationships and clinical implications. Cell Cycle 2014; 13 (3): 353-7. 17. Marisa L, de Reyniès A, Duval A, Selves J, Gaub MP, Vescovo L, et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med 2013; 10 (5): e1001453. 18. Domingo E, Ramamoorthy R, Oukrif D, Rosmarin D, Presz M, Wang H, et al. Use of multivariate analysis to suggest a new molecular classification of colorectal cancer. J Pathol 2013; 229 (3): 441-8. 19. Guinney J, Dienstmann R, Wang X, de Reyniès A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med 2015; 21 (11): 1350-6. 20. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19: 5444. 21. Cawkwell L1, Lewis FA, Quirke P. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/ MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer 1994; 70 (5): 813-8. 22. Chang SC, Lin JK, Lin TC, Liang WY. Loss of heterozygosity: an independent prognostic factor of colorectal cancer. World J Gastroenterol 2005; 11 (6): 778-84. 23. Wielandt AM, Zárate AJ, Hurtado C, Orellana P, Álvarez K, Pinto E, et al. Lynch syndrome: selection of families by microsatellite instability and immunohistochemistry. Rev Med Chile 2012; 140 (9): 1132-9. 24. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, et al. Methy Light: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000; 28 (8): E32. 25. Berg M, Hagland HR, Søreide K. Comparison of CpG island methylator phenotype (CIMP) frequency in colon cancer using different probe- and gene-specific scoring alternatives on recommended multi-gene panels. PLoS One 2014; 9 (1): e86657. 26. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, et al. CpG island methylator phe- Rev Med Chile 2017; 145: 419-430


Abril_2107
To see the actual publication please follow the link above